losartan has been researched along with enalaprilat anhydrous in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 33 (54.10) | 18.2507 |
2000's | 18 (29.51) | 29.6817 |
2010's | 9 (14.75) | 24.3611 |
2020's | 1 (1.64) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Avdeef, A; Tam, KY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Beierwaltes, WH; Carretero, OA; Sigmon, DH | 1 |
Carmines, PK; Inscho, EW; Navar, LG; Ohishi, K | 1 |
Bunting, PB; Cartwright, ME; Frank, JD; Gibson, RE; Schorn, TW; Siegl, PK; Thorpe, HH | 1 |
Mah, SC; Schnell, C; Wood, JM | 1 |
Boutinet, S; Fleetwood, G; Meier, M; Wood, JM | 1 |
Chen, C; Lokhandwala, MF | 1 |
Kunert-Radek, J; Mucha, S; Pawlikowski, M; Pisarek, H; Sepien, H; Stawowy, A | 1 |
Arnet, U; Lüscher, TF; Siebenmann, R; Turina, M; von Segesser, L; Yang, Z | 1 |
Berdeaux, A; Giudicelli, JF; Richard, V | 1 |
Caride, VJ; Fernandez, LA; Näveri, L; Strömberg, C; Wicke, JD | 1 |
Cumin, F; De Gasparo, M; Levens, N; Macari, D; Whitebread, S | 1 |
Madwed, JB; Winquist, RJ | 1 |
Feng, CJ; Kadowitz, PJ; Nossaman, BD; Wang, J | 1 |
Castillo, G; Esteban, S; Orce, G | 1 |
Berdeaux, A; Ghaleh, B; Giudicelli, JF; Richard, V | 1 |
Barbant, SD; Chatterjee, K; Gupta, M; MacGregor, JS; Redberg, R; Sudhir, K; Yock, PG | 1 |
Cupples, WA | 1 |
Mimran, A; Nafrialdi, N; Ribstein, J; Valentin, JP | 1 |
Buckman, S; Burns, KD; Iacovitti, M; Levine, DZ | 1 |
de Champlain, J; Foucart, S; Oster, L; Patrick, SK | 1 |
Arendshorst, WJ; Chatziantoniou, C; Kurtz, A; Ruan, X; Wagner, C | 1 |
Armentano, RL; Barra, JG; Cabrera Fischer, EI; Levenson, J; Pichel, RH; Simon, A | 1 |
Cardinal, R; de Champlain, J; K-Laflamme, A; Oster, L | 1 |
Baum, M; Quan, A | 1 |
Baum, M; Quan, A; Quigley, R | 1 |
Adam, A; Blais, C; Drapeau, G; Gervais, N; Lamontagne, D; Raymond, P; Venneman, I | 1 |
Fleischhauer, J; Hanrath, P; Klues, HG; Montino, H; Schwarz, ER; vom Dahl, J | 1 |
Cardinal, R; de Champlain, J; Foucart, S; K-Laflamme, A; Lambert, C; Moreau, P | 1 |
Gaudet, EA; Godwin, SJ; Head, GA | 1 |
Gelpi, RJ; Morales, C; Rodríguez, M; Scapín, O | 1 |
Angus, JA; Whorlow, SL; Wright, CE | 1 |
Barbe, F; Crozatier, B; Guyene, TT; Hittinger, L; Houël, R; Su, J | 1 |
Janssen, BJ; Oosting, J; Struijker-Boudier, HA | 1 |
Danser, AH; Kroon, I; Saris, JJ; Schalekamp, MA; van Dijk, MA | 1 |
Hayashi, Y; Hisa, H; Satoh, S; Suzuki-Kusaba, M; Yamaguchi, N; Yoshida, M | 1 |
Kingma, JG; Rouleau, JR; Simard, D | 1 |
Connell, JM; Hillier, C; McDonald, JE; McMurray, JJ; Padmanabhan, N; Petrie, MC | 1 |
Fetics, B; Hare, JM; Kass, DA; Maughan, WL; Pak, PH; Wittstein, IS | 1 |
Clanachan, AS; Dyck, JR; Ford, WR; Jugdutt, BI; Kumar, D; Lopaschuk, GD; Xu, Y | 1 |
Doverspike, A; Hentosz, T; Huerbin, R; Nikolaidis, LA; Shannon, RP | 1 |
Epelde, F; Heras, M; Pérez-Villa, F; Rigol, M; Roig, E; Roqué, M; Sanz, G; Solanes, N | 1 |
De Mello, WC | 1 |
Clanachan, AS; Ford, WR; Jugdutt, BI; Kumar, D; Menon, V | 1 |
Beier, K; Bellahcene, M; Buser, PT; Butz, S; Driamov, S; Remondino, A; Zaugg, CE; Ziegler, A | 1 |
De Mello, WC; Monterrubio, J | 1 |
Adler, S; Huang, H | 1 |
Padilha, AS; Rossoni, LV; Vassallo, DV; Xavier, FE | 1 |
Abassi, Z; Assady, S; Khankin, E; Kositch, Z; Lewin, M; Nakhoul, F; Ramadan, R; Yaccob, A | 1 |
Liu, LY; Liu, YH; Song, T; Wu, SJ; You, Y | 1 |
Angeli, JK; Casali, EA; Fürstenau, CR; Ramos, DB; Sarkis, JJ; Souza, DO; Stefanon, I; Vassallo, DV | 1 |
Huang, YS; Shi, XH; Teng, M; Xiao, R; Zhang, Q | 1 |
Kang, YM; Qi, J; Qin, DN; Su, Q; Suo, YP; Yang, Q; Yu, XJ; Yue, LY; Zhang, DM; Zhu, GQ | 1 |
Hillfinger, J; Larsen, SD; Lipka, E; Okawada, M; Teitelbaum, DH; Wilson, MW | 1 |
Astori, G; Bernardi, M; Bozza, A; Catanzaro, D; Chieregato, K; Merlo, A | 1 |
2 review(s) available for losartan and enalaprilat anhydrous
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Regulation of proximal tubule transport by angiotensin II.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biological Transport; Enalaprilat; Homeostasis; Kidney Tubules, Proximal; Losartan; Rats; Receptors, Angiotensin; Renin-Angiotensin System | 1997 |
1 trial(s) available for losartan and enalaprilat anhydrous
Article | Year |
---|---|
Functional importance of angiotensin-converting enzyme-dependent in situ angiotensin II generation in the human forearm.
Topics: Adolescent; Adult; Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Brachial Artery; Enalaprilat; Endothelium, Vascular; Forearm; Humans; Losartan; Male; Middle Aged; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Regional Blood Flow; Vasoconstriction | 2000 |
58 other study(ies) available for losartan and enalaprilat anhydrous
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Angiotensin dependence of endothelium-mediated renal hemodynamics.
Topics: Angiotensin II; Animals; Arginine; Biphenyl Compounds; Blood Pressure; Enalaprilat; Endothelium, Vascular; Hemodynamics; Imidazoles; Kinins; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Renal Circulation; Tetrazoles | 1992 |
EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles.
Topics: Acetylcholine; Angiotensin II; Animals; Arginine; Arterioles; Biphenyl Compounds; Drug Interactions; Enalaprilat; Imidazoles; In Vitro Techniques; Kidney Medulla; Losartan; Male; Nitric Oxide; Nitroarginine; Osmolar Concentration; Rats; Renal Circulation; Tetrazoles; Vasoconstriction | 1992 |
Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoradiography; Binding, Competitive; Biphenyl Compounds; Blood Pressure; Enalaprilat; Heart Rate; Imidazoles; Iodine Radioisotopes; Kidney Cortex; Losartan; Macaca mulatta; Male; Pyridines; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Renin; Tetrazoles | 1991 |
Comparison of the acute hypotensive effects of renin inhibition, converting enzyme inhibition, and angiotensin II antagonism in rats.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Enalaprilat; Hypertension; Hypertension, Renal; Imidazoles; Losartan; Oligopeptides; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Renin; Time Factors | 1990 |
Involvement of the renin-angiotensin system in ischemic damage and reperfusion arrhythmias in the isolated perfused rat heart.
Topics: Animals; Arrhythmias, Cardiac; Creatine Kinase; Enalaprilat; Imidazoles; In Vitro Techniques; Losartan; Male; Myocardial Reperfusion Injury; Oligopeptides; Perfusion; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Tetrazoles | 1991 |
Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Bradykinin; Diuresis; Dopamine Agonists; Drug Synergism; Enalaprilat; Fenoldopam; Glomerular Filtration Rate; Imidazoles; Kidney; Losartan; Male; Natriuresis; Rats; Rats, Sprague-Dawley; Tetrazoles | 1995 |
Is estrogen-induced pituitary hyperplasia and hyperprolactinaemia mediated by angiotensin II?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Cell Division; Diethylstilbestrol; Enalapril; Enalaprilat; Estrogens; Estrogens, Non-Steroidal; Humans; Hyperpituitarism; Hyperplasia; Hyperprolactinemia; Imidazoles; Losartan; Prolactin; Pyridines; Rats; Rats, Inbred F344; Rats, Wistar; Tetrazoles; Tumor Cells, Cultured | 1995 |
Different effects of angiotensin-converting enzyme inhibition in human arteries and veins.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Bradykinin; Enalaprilat; Endothelium, Vascular; Humans; Imidazoles; In Vitro Techniques; Losartan; Mammary Arteries; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Saphenous Vein; Tetrazoles | 1993 |
Systemic and coronary effects of the angiotensin II receptor antagonist EXP3174 in dogs.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Coronary Circulation; Dogs; Enalaprilat; Female; Furosemide; Hemodynamics; Imidazoles; Losartan; Male; Renin-Angiotensin System; Tetrazoles | 1993 |
Angiotensin AT2 receptor stimulation increases survival in gerbils with abrupt unilateral carotid ligation.
Topics: Animals; Biphenyl Compounds; Brain Ischemia; Carotid Arteries; Dose-Response Relationship, Drug; Drug Interactions; Enalaprilat; Gerbillinae; Imidazoles; Ligation; Losartan; Male; Pyridines; Receptors, Angiotensin; Regional Blood Flow; Survival Analysis; Tetrazoles | 1994 |
Renal actions of the angiotensin AT2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Enalaprilat; Imidazoles; Kidney; Losartan; Male; Oligopeptides; Pyridines; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Vascular Resistance | 1994 |
Effects of losartan (DuP753) and enalaprilat on the mean arterial pressure response to phenylephrine.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Enalaprilat; Heart Rate; Imidazoles; Infusions, Intravenous; Losartan; Phenylephrine; Rabbits; Renin-Angiotensin System; Tetrazoles | 1994 |
Analysis of angiotensins I, II, and III in pulmonary vascular bed of the rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Blood Vessels; Captopril; Enalaprilat; Imidazoles; In Vitro Techniques; Losartan; Male; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Tetrazoles | 1994 |
Oxytocic effect of trypsin on the isolated rat uterus.
Topics: Angiotensin I; Angiotensin II; Animals; Biphenyl Compounds; Bradykinin; Dose-Response Relationship, Drug; Enalaprilat; Female; Imidazoles; In Vitro Techniques; Isometric Contraction; Losartan; Oxytocin; Pepstatins; Rats; Saralasin; Tetrazoles; Trypsin; Uterine Contraction; Uterus | 1994 |
Comparison of the effects of EXP3174, an angiotensin II antagonist and enalaprilat on myocardial infarct size in anaesthetized dogs.
Topics: Anesthesia; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Coronary Circulation; Disease Models, Animal; Dogs; Enalaprilat; Female; Furosemide; Heart Rate; Imidazoles; Injections, Intravenous; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Renin-Angiotensin System; Tetrazoles | 1993 |
Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Intravascular two-dimensional and Doppler ultrasound studies.
Topics: Adenosine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Blood Flow Velocity; Coronary Circulation; Coronary Vessels; Dogs; Enalaprilat; Female; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Rest; Tetrazoles; Ultrasonography; Vasodilation | 1993 |
Angiotensin II conditions the slow component of autoregulation of renal blood flow.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Enalaprilat; Homeostasis; Imidazoles; Kidney; Kinetics; Losartan; Male; Perfusion; Pressure; Rats; Rats, Sprague-Dawley; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasodilation | 1993 |
Endogenous angiotensin II modulates the effect of atrial natriuretic peptide on extracellular fluid partition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Biphenyl Compounds; Blood Pressure; Captopril; Enalaprilat; Extracellular Space; Hematocrit; Imidazoles; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles | 1993 |
Role of angiotensin II in dietary modulation of rat late distal tubule bicarbonate flux in vivo.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bicarbonates; Biphenyl Compounds; Diet; Enalaprilat; Fasting; Imidazoles; Kidney Tubules, Distal; Losartan; Male; Perfusion; Rats; Rats, Sprague-Dawley; Renin; Sodium Chloride; Tetrazoles | 1996 |
Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Body Weight; Bradykinin; Enalaprilat; Heart Atria; Imidazoles; Losartan; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Tetrazoles | 1996 |
Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
Topics: Actins; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Cloning, Molecular; Culture Techniques; DNA, Complementary; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enalaprilat; Gene Expression Regulation; Imidazoles; Kidney; Losartan; Male; Oligopeptides; Polymerase Chain Reaction; Pyridines; Rats; Rats, Wistar; Receptors, Angiotensin; Renal Artery; Renal Circulation; Ribonucleases; RNA, Messenger; Sodium, Dietary; Tetrazoles; Vasoconstrictor Agents | 1997 |
In vivo angiotensin II receptor blockade and converting enzyme inhibition on canine aortic viscoelasticity.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Dogs; Elasticity; Enalaprilat; Hypertension, Renovascular; Imidazoles; Losartan; Male; Reference Values; Tetrazoles; Viscosity | 1997 |
Effects of renin-angiotensin blockade on sympathetic reactivity and beta-adrenergic pathway in the spontaneously hypertensive rat.
Topics: Adenylyl Cyclases; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Enalaprilat; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Losartan; Male; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, beta; Reflex; Renin-Angiotensin System; Sympathetic Nervous System; Tetrazoles | 1997 |
Effect of luminal angiotensin II on rabbit proximal convoluted tubule bicarbonate absorption.
Topics: Absorption; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bicarbonates; Biological Transport; Enalaprilat; Female; Imidazoles; Kidney Tubules, Proximal; Losartan; Pyridines; Rabbits | 1997 |
Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study.
Topics: Amino Acid Sequence; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies; Bradykinin; Cross Reactions; Dogs; Enalaprilat; Humans; Kinetics; Losartan; Myocardium; Peptidyl-Dipeptidase A; Protease Inhibitors; Rabbits; Rats; Species Specificity; Substrate Specificity; Thiorphan | 1997 |
Angiotensin II receptor antagonist EXP 3174 reduces infarct size comparable with enalaprilat and augments preconditioning in the pig heart.
Topics: Angiotensin Receptor Antagonists; Animals; Enalaprilat; Hemodynamics; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardium; Swine; Tetrazoles | 1997 |
Sympathetic functions in NG-nitro-L-arginine-methyl-ester-induced hypertension: modulation by the renin-angiotensin system.
Topics: Adenylyl Cyclases; Animals; Antihypertensive Agents; Enalaprilat; Enzyme Inhibitors; Epinephrine; GTP-Binding Proteins; Heart; Hemodynamics; Hypertension; In Vitro Techniques; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Norepinephrine; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Renin-Angiotensin System; Sympathetic Nervous System | 1998 |
Role of central catecholaminergic pathways in the actions of endogenous ANG II on sympathetic reflexes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Ascorbic Acid; Baroreflex; Blood Pressure; Brain; Enalaprilat; Female; Heart Rate; Hypoxia; Kidney; Losartan; Male; Oxidopamine; Rabbits; Reference Values; Renin-Angiotensin System; Sympathetic Nervous System | 1998 |
Comparison of the effects of ACE inhibition with those of angiotensin II receptor antagonism on systolic and diastolic myocardial stunning in isolated rabbit heart.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Diastole; Enalaprilat; In Vitro Techniques; Losartan; Myocardial Contraction; Myocardial Stunning; Rabbits; Systole | 1998 |
Endogenous angiotensin II and bradykinin delay and attenuate the hypotension after N-type calcium channel blockade in conscious rabbits.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Bradykinin; Calcium Channel Blockers; Dose-Response Relationship, Drug; Enalaprilat; Heart Rate; Hypotension; Losartan; Nasopharynx; omega-Conotoxin GVIA; Peptides; Pressoreceptors; Propranolol; Rabbits; Renin-Angiotensin System | 1998 |
Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure. Differential acute effects according to the renin-angiotensin system activation.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Dogs; Enalaprilat; Female; Heart Failure; Hemodynamics; Imidazoles; Losartan; Male; Renin; Renin-Angiotensin System; Tetrazoles; Vasodilation | 1999 |
Timed inhibition of the renin-angiotensin system suppresses the rise in blood pressure upon awakening in spontaneously hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Chronotherapy; Enalaprilat; Hypertension; Infusions, Intravenous; Losartan; Male; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 1999 |
Interaction between norepinephrine release and intrarenal angiotensin II formation during renal nerve stimulation in dogs.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Dogs; Enalaprilat; Female; Kidney; Losartan; Male; Norepinephrine; Renal Circulation; Sympathetic Nervous System; Time Factors | 2000 |
Effect of angiotensin inhibition on the coronary artery lower pressure limit in anesthetized dogs.
Topics: Angiotensin Receptor Antagonists; Animals; Coronary Circulation; Coronary Vessels; Diastole; Dogs; Enalaprilat; Losartan; Male; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2000 |
Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease.
Topics: Acetylcholine; Aged; Angina Pectoris; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteries; Bradykinin; Chymases; Enalaprilat; Female; Heart Failure; Humans; In Vitro Techniques; Losartan; Male; Middle Aged; Oligopeptides; Peptidyl-Dipeptidase A; Serine Endopeptidases; Vascular Resistance; Vasoconstriction | 2001 |
Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiomyopathy, Dilated; Compliance; Depression, Chemical; Diastole; Dobutamine; Enalaprilat; Enzyme Inhibitors; Female; Heart; Hemodynamics; Humans; Losartan; Male; Middle Aged; Myocardial Contraction; Myocardium; Nitric Oxide; omega-N-Methylarginine; Ventricular Dysfunction, Left | 2001 |
AT(1) and AT(2) receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts.
Topics: Adenosine; Adrenergic alpha-Agonists; Anaerobiosis; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Cyclic GMP; Enalaprilat; Gene Expression Regulation; Heart; Hemodynamics; In Vitro Techniques; Losartan; Mitogen-Activated Protein Kinases; Myocardial Reperfusion; Myocardial Reperfusion Injury; p38 Mitogen-Activated Protein Kinases; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Time Factors; Ventricular Function, Left | 2002 |
Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cardiomyopathy, Dilated; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Enalaprilat; Enzyme Inhibitors; Hemodynamics; Kinetics; Losartan; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Receptor, Angiotensin, Type 1; Receptor, Bradykinin B2; Receptors, Bradykinin; Regional Blood Flow; Vasodilator Agents | 2002 |
Enalaprilat, losartan and LU 135252 in coronary blood flow regulation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bradykinin; Coronary Circulation; Enalaprilat; Female; Losartan; Male; Phenylpropionates; Pyrimidines; Swine | 2003 |
Further studies on the effect of intracellular angiotensins on heart cell communication: on the role of endogenous angiotensin II.
Topics: Angiotensin II; Animals; Cell Communication; Cricetinae; Dose-Response Relationship, Drug; Enalapril; Enalaprilat; Losartan; Male; Mesocricetus; Myocardium; Patch-Clamp Techniques; Peptides; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Renin-Angiotensin System; Temperature; Time Factors | 2003 |
Effect of angiotensin II type 2 receptor blockade on activation of mitogen-activated protein kinases after ischemia-reperfusion in isolated working rat hearts.
Topics: Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Cardiac Output; Coronary Circulation; Cyclic GMP; Disease Models, Animal; Enalaprilat; Enzyme Activation; Heart; Losartan; Male; Mitogen-Activated Protein Kinases; Models, Cardiovascular; Phosphorylation; Protein Kinase C; Protein Kinase C-epsilon; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger | 2003 |
Losartan but not enalaprilat acutely reduces reperfusion ventricular tachyarrhythmias in hypertrophied rat hearts after low-flow ischaemia.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Enalaprilat; Heart; Hypertrophy, Left Ventricular; In Vitro Techniques; Losartan; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tachycardia, Ventricular; Ventricular Fibrillation | 2004 |
Intracellular and extracellular angiotensin II enhance the L-type calcium current in the failing heart.
Topics: Adenosine Triphosphatases; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Calcium Channels, L-Type; Calcium Signaling; Cardiomyopathies; Cells, Cultured; Cricetinae; Enalaprilat; Enzyme Activation; Extracellular Fluid; Intracellular Fluid; Losartan; Male; Mesocricetus; Myocytes, Cardiac; Protein Kinase C; Sarcoplasmic Reticulum; Staurosporine; Thapsigargin | 2004 |
Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase.
Topics: Acetophenones; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Bradykinin; Enalaprilat; Free Radical Scavengers; Immunoblotting; In Vitro Techniques; Kidney; Kidney Cortex; Losartan; NADPH Oxidases; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Oxidative Stress; Oxygen Consumption; Rats; Rats, Inbred SHR; Rats, Inbred WKY; S-Nitroso-N-Acetylpenicillamine; Superoxide Dismutase | 2004 |
Ouabain at nanomolar concentration promotes synthesis and release of angiotensin II from the endothelium of the tail vascular bed of spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Blood Pressure; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Enalaprilat; Endothelium, Vascular; Glucose; Hexamethonium; Injections, Intravenous; Losartan; Male; Muscle, Smooth, Vascular; Ouabain; Perfusion; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium-Potassium-Exchanging ATPase; Tail; Time Factors; Tromethamine; Vasodilation | 2004 |
Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Doxorubicin; Enalaprilat; Enzyme Inhibitors; Fluorescent Antibody Technique; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Kidney Glomerulus; Losartan; Male; Membrane Proteins; Mycophenolic Acid; Nephrotic Syndrome; Protein Synthesis Inhibitors; Proteinuria; Pyridines; Rats; Rats, Sprague-Dawley; Thiazepines | 2005 |
Impairment of endothelium-dependent relaxation of rat aortas by homocysteine thiolactone and attenuation by captopril.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Captopril; Dose-Response Relationship, Drug; Enalaprilat; Endothelium, Vascular; Free Radicals; Homocysteine; Losartan; Malondialdehyde; Nitric Oxide; Nitroprusside; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Vasodilation | 2007 |
Gadolinium increases the vascular reactivity of rat aortic rings.
Topics: Animals; Antihypertensive Agents; Aorta; Dose-Response Relationship, Drug; Enalaprilat; Endothelium, Vascular; Female; Gadolinium; Losartan; Male; NG-Nitroarginine Methyl Ester; Phenylephrine; Rats; Rats, Wistar; Vasoconstriction; Vasodilation | 2011 |
Myocardial autophagy after severe burn in rats.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Biomarkers; Biphenyl Compounds; Burns; Enalaprilat; Fluorescent Antibody Technique; Heart Function Tests; In Vitro Techniques; Losartan; Male; Microtubule-Associated Proteins; Myocardium; Onium Compounds; Rats; Rats, Sprague-Dawley | 2012 |
Chronic infusion of enalaprilat into hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension and cardiac hypertrophy by restoring neurotransmitters and cytokines.
Topics: Angiotensin II; Animals; Cardiomegaly; Chemokine CCL2; Enalaprilat; gamma-Aminobutyric Acid; Glutamic Acid; Heart; Hypertension; Interleukin-10; Interleukin-1beta; Interleukin-6; Kidney; Losartan; Male; Neurotransmitter Agents; Norepinephrine; Organ Size; Paraventricular Hypothalamic Nucleus; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2014 |
Blockade of the renin-angiotensin system prevents acute and immunologically relevant colitis in murine models.
Topics: Acute Disease; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Colitis; Cyclooxygenase Inhibitors; Disease Models, Animal; Enalaprilat; Losartan; Mice; Mice, Inbred C57BL; Piroxicam; Renin-Angiotensin System | 2016 |
Enalaprilat and losartan decrease erythroid precursors frequency in cells from patients with polycythemia vera.
Topics: Enalaprilat; Erythrocytes; Humans; Losartan; Polycythemia; Polycythemia Vera | 2023 |